Evaluation of the effects of IL‑22 on the proliferation and differentiation of keratinocytes in vitro

Zhuang,Le; Ma,Weiyuan; Yan,Jianjun; Zhong,Hua

doi:10.3892/mmr.2020.11348

Evaluation of the effects of IL‑22 on the proliferation and differentiation of keratinocytes in vitro

Authors:
- Le Zhuang
- Weiyuan Ma
- Jianjun Yan
- Hua Zhong
View Affiliations

Affiliations: Department of Dermatology, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China
Published online on: July 20, 2020 https://doi.org/10.3892/mmr.2020.11348
Pages: 2715-2722
Copyright: © Zhuang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Psoriasis is one of the most common chronic inflammatory skin diseases, it is characterized by hyperproliferation of keratinocytes and infiltration of inflammatory cells. Several in vitro studies have reported that interleukin (IL)‑22 is involved in excessive proliferation and abnormal differentiation of human keratinocytes. However, the association between IL‑22 and CCAAT enhancer binding protein α (C/EBPα) in the pathogenesis of psoriasis remains unclear. Therefore, the present study aimed to investigate the association between IL‑22 and C/EBPα, and the effects of IL‑22 on the proliferation and differentiation of keratinocytes. Keratinocytes were treated with different concentrations of IL‑22 (30, 60 and 90 ng/ml) and subsequently cells were collected at different time intervals. The expression levels of the key molecules of the mitogen‑activated protein kinase (MAPK) signaling pathway were detected using western blot analysis. In addition, the effect of IL‑22 on the proliferation rate of keratinocytes and the mRNA expression levels of C/EBPα were determined using a Cell Counting Kit‑8 assay and reverse transcription‑quantitative PCR, respectively. Furthermore, keratinocytes were transfected with C/EBPα small interfering (si)RNA or control using Lipofectamine® 2000. The results revealed that IL‑22 significantly induced the proliferation of keratinocytes and the expression of phosphorylated (p)‑JNK, p‑ERK and p‑p38 (P<0.05). Additionally, IL‑22 significantly inhibited the differentiation of keratinocytes, and the mRNA and protein expression of C/EBPα (P<0.05). Furthermore, downregulation of C/EBPα increased the proliferation rate of keratinocytes and reduced the expression levels of cytokeratin 10 and involucrin. Therefore, these results suggested that the effect of IL‑22 on the proliferation and differentiation of keratinocytes may be mediated via the regulation of the MAPK signaling pathway and the expression of C/EBPα.

View Figures

View References

1	Schön MP and Boehncke WH: Psoriasis. N Engl J Med. 352:2715–1912. 2005. View Article : Google Scholar
2	Lowes MA, Bowcock AM and Krueger JG: Pathogenesis and therapy of psoriasis. Nature. 445:866–873. 2007. View Article : Google Scholar : PubMed/NCBI
3	Bos JD, de Rie MA, Teunissen MB and Piskin G: Psoriasis: Dysregulation of innate immunity. Br J Dermatol. 152:1098–1107. 2005. View Article : Google Scholar : PubMed/NCBI
4	Di Cesare A, Di Meglio P and Nestle FO: The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol. 129:1339–1350. 2009. View Article : Google Scholar : PubMed/NCBI
5	Boniface K, Bernard FX, Garcia M, Gurney AL, Lecron JC and Morel F: IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol. 174:3695–3702. 2005. View Article : Google Scholar : PubMed/NCBI
6	Ekman AK, Bivik Eding C, Rundquist I and Enerbäck C: IL-17 and IL-22 promote keratinocyte stemness in the germinative compartment in psoriasis. J Invest Dermatol. 139:1564–1573.e8. 2019. View Article : Google Scholar : PubMed/NCBI
7	Jiang M, Ma W, Gao Y, Jia K, Zhang Y, Liu H and Sun Q: IL-22-induced miR-122-5p promotes keratinocyte proliferation by targeting Sprouty2. Exp Dermatol. 26:368–374. 2017. View Article : Google Scholar : PubMed/NCBI
8	Boehncke WH: Etiology and pathogenesis of psoriasis. Rheum Dis Clin North Am. 41:665–675. 2015. View Article : Google Scholar : PubMed/NCBI
9	Nestle FO, Kaplan DH and Barker J: Psoriasis. N Engl J Med. 361:496–509. 2009. View Article : Google Scholar : PubMed/NCBI
10	Lejeune D, Dumoutier L, Constantinescu S, Kruijer W, Schuringa JJ and Renauld JC: Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol Chem. 277:33676–33682. 2002. View Article : Google Scholar : PubMed/NCBI
11	Yu J, Xiao Z, Zhao R, Lu C and Zhang Y: Paeoniflorin suppressed IL-22 via p38 MAPK pathway and exerts anti-psoriatic effect. Life Sci. 180:17–22. 2017. View Article : Google Scholar : PubMed/NCBI
12	Wolk K, Haugen HS, Xu W, Witte E, Waggie K, Anderson M, Vom Baur E, Witte K, Warszawska K, Philipp S, et al: IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not. J Mol Med (Berl). 87:523–536. 2009. View Article : Google Scholar : PubMed/NCBI
13	Lopez RG, Garcia-Silva S, Moore SJ, Bereshchenko O, Martinez-Cruz AB, Ermakova O, Kurz E, Paramio JM and Nerlov C: C/EBPalpha and beta couple interfollicular keratinocyte proliferation arrest to commitment and terminal differentiation. Nat Cell Biol. 11:1181–1190. 2009. View Article : Google Scholar : PubMed/NCBI
14	Zhang ZC, Liu Y, Li SF, Guo L, Zhao Y, Qian SW, Wen B, Tang QQ and Li X: Suv39h1 mediates AP-2α-dependent inhibition of C/EBPα expression during adipogenesis. Mol Cell Biol. 34:2330–2338. 2014. View Article : Google Scholar : PubMed/NCBI
15	Thompson EA, Zhu S, Hall JR, House JS, Ranjan R, Burr JA, He YY, Owens DM and Smart RC: C/EBPα expression is downregulated in human nonmelanoma skin cancers and inactivation of C/EBPα confers susceptibility to UVB-induced skin squamous cell carcinomas. J Invest Dermatol. 131:1339–1346. 2011. View Article : Google Scholar : PubMed/NCBI
16	Weinstein GD, McCullough JL and Ross PA: Cell kinetic basis for pathophysiology of psoriasis. J Invest Dermatol. 85:579–583. 1985. View Article : Google Scholar : PubMed/NCBI
17	Bernard BA, Asselineau D, Schaffar-Deshayes L and Darmon MY: Abnormal sequence of expression of differentiation markers in psoriatic epidermis: Inversion of two steps in the differentiation program? J Invest Dermatol. 90:801–805. 1988. View Article : Google Scholar : PubMed/NCBI
18	Duvic M, Asano AT, Hager C and Mays S: The pathogenesis of psoriasis and the mechanism of action of tazarotene. J Am Acad Dermatol. 39:S129–S133. 1998. View Article : Google Scholar : PubMed/NCBI
19	Bernerd F, Magnaldo T and Darmon M: Delayed onset of epidermal differentiation in psoriasis. J Invest Dermatol. 98:902–910. 1992. View Article : Google Scholar : PubMed/NCBI
20	Sallusto F and Lanzavecchia A: Heterogeneity of CD4+ memory T cells: Functional modules for tailored immunity. Eur J Immunol. 39:2076–2082. 2009. View Article : Google Scholar : PubMed/NCBI
21	Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, Pallotta S, Cianfarani F, Odorisio T, Traidl-Hoffmann C, Behrendt H, et al: Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest. 119:3573–3585. 2009.PubMed/NCBI
22	Zenewicz LA and Flavell RA: IL-22 and inflammation: Leukin′ through a glass onion. Eur J Immunol. 38:3265–3268. 2008. View Article : Google Scholar : PubMed/NCBI
23	Xie MH, Aggarwal S, Ho WH, Foster J, Zhang Z, Stinson J, Wood WI, Goddard AD and Gurney AL: Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem. 275:31335–31339. 2000. View Article : Google Scholar : PubMed/NCBI
24	Ma HL, Liang S, Li J, Napierata L, Brown T, Benoit S, Senices M, Gill D, Dunussi-Joannopoulos K, Collins M, et al: IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest. 118:597–607. 2008.PubMed/NCBI
25	Weber GF, Gaertner FC, Erl W, Janssen KP, Blechert B, Holzmann B, Weighardt H and Essler M: IL-22-mediated tumor growth reduction correlates with inhibition of ERK1/2 and AKT phosphorylation and induction of cell cycle arrest in the G2-M phase. J Immunol. 177:8266–8272. 2006. View Article : Google Scholar : PubMed/NCBI
26	Johansen C, Kragballe K, Westergaard M, Henningsen J, Kristiansen K and Iversen L: The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin. Br J Dermatol. 152:37–42. 2005. View Article : Google Scholar : PubMed/NCBI
27	Zhang X, Yang D, Ma S and Liu H: Up-regulation of activities of mitogen-activated protein kinase in psoriatic lesions. J Dermatol Sci. 37:118–119. 2005. View Article : Google Scholar : PubMed/NCBI
28	Funding AT, Johansen C, Kragballe K and Iversen L: Mitogen- and stress-activated protein kinase 2 and cyclic AMP response element binding protein are activated in lesional psoriatic epidermis. J Invest Dermatol. 127:2012–2019. 2007. View Article : Google Scholar : PubMed/NCBI
29	Johnson PF and McKnight SL: Eukaryotic transcriptional regulatory proteins. Annu Rev Biochem. 58:799–839. 1989. View Article : Google Scholar : PubMed/NCBI
30	Maytin EV and Habener JF: Transcription factors C/EBP alpha, C/EBP beta, and CHOP (Gadd153) expressed during the differentiation program of keratinocytes in vitro and in vivo. J Invest Dermatol. 110:238–246. 1998. View Article : Google Scholar : PubMed/NCBI
31	Oh HS and Smart RC: Expression of CCAAT/enhancer binding proteins (C/EBP) is associated with squamous differentiation in epidermis and isolated primary keratinocytes and is altered in skin neoplasms. J Invest Dermatol. 110:939–945. 1998. View Article : Google Scholar : PubMed/NCBI
32	Loomis KD, Zhu S, Yoon K, Johnson PF and Smart RC: Genetic ablation of CCAAT/enhancer binding protein alpha in epidermis reveals its role in suppression of epithelial tumorigenesis. Cancer Res. 67:6768–6776. 2007. View Article : Google Scholar : PubMed/NCBI
33	McKnight SL: McBindall-a better name for CCAAT/enhancer binding proteins? Cell. 107:259–261. 2001. View Article : Google Scholar : PubMed/NCBI
34	Wang H, Iakova P, Wilde M, Welm A, Goode T, Roesler WJ and Timchenko NA: C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4. Mol Cell. 8:817–828. 2001. View Article : Google Scholar : PubMed/NCBI